Published in
American Association for the Advancement of Science, Science Translational Medicine, 389(9), 2017
DOI: 10.1126/scitranslmed.aal2668
Links
Tools
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma
Journal article published in 2017 by
Salomon Manier 
,
Daisy Huynh ,
Yu J. Shen ,
Jia Zhou ,
Timur Yusufzai,
Karma Z. Salem ,
Richard Y. Ebright ,
Jiantao Shi,
Jihye Park ,
Siobhan V. Glavey ,
William G. Devine,
Chia-Jen Liu,
Xavier Leleu,
Bruno Quesnel,
Catherine Roche-Lestienne
and other authors.
,
Daisy Huynh ,
Yu J. Shen ,
Jia Zhou ,
Timur Yusufzai,
Karma Z. Salem ,
Richard Y. Ebright ,
Jiantao Shi,
Jihye Park ,
Siobhan V. Glavey ,
William G. Devine,
Chia-Jen Liu,
Xavier Leleu,
Bruno Quesnel,
Catherine Roche-Lestienne
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Targeting translation initiation in multiple myeloma induces inhibition of a specific oncogenic translation program.